Trials / Completed
CompletedNCT02053025
Appetite Regulation and Mycoprotein
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Imperial College London · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to investigate the effect of eating various levels of mycoprotein (Quorn) on feelings of appetite, energy intake and levels of gut hormones in overweight volunteers.
Detailed description
Owing to its relatively high protein and fibre content, mycoprotein presents an attractive food product to improve appetite regulation and postprandial glycaemic and insulin responses in overweight and obese individuals at risk of developing T2DM
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | mycoprotein | |
| DIETARY_SUPPLEMENT | control protein |
Timeline
- Start date
- 2010-03-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2014-02-03
- Last updated
- 2019-10-16
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02053025. Inclusion in this directory is not an endorsement.